These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 1623766)

  • 1. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.
    Orlowski JP; Wateska L
    Chest; 1992 Jul; 102(1):270-3. PubMed ID: 1623766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical relationships between drug companies and the medical profession.
    Rosner F
    Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
    Hemminki E; Karttunen T; Hovi SL; Karro H
    Soc Sci Med; 2004 Jan; 58(1):89-97. PubMed ID: 14572923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids.
    Morse E; Fujiwara RJT; Mehra S
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):442-448. PubMed ID: 29865931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmaceutical sales representatives on physician antibiotic prescribing.
    Cleary JD
    J Pharm Technol; 1992; 8(1):27-9. PubMed ID: 10118197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in drug prescribing patterns related to commercial company funding of continuing medical education.
    Bowman MA; Pearle DL
    J Contin Educ Health Prof; 1988; 8(1):13-20. PubMed ID: 10294441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
    Datta A; Dave D
    Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A physician survey of the effect of drug sample availability on physicians' behavior.
    Chew LD; O'Young TS; Hazlet TK; Bradley KA; Maynard C; Lessler DS
    J Gen Intern Med; 2000 Jul; 15(7):478-83. PubMed ID: 10940134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counter sampling combined with medical provider education: do they alter prescribing behavior?
    Erramouspe J; Bailey JM; Cleveland KW; Casperson K; Hunt TL; Cady PS
    Consult Pharm; 2006 Aug; 21(8):636-42. PubMed ID: 17076590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the physician contribution to managed care pharmacy expenses: a random effects approach.
    Cowen ME; Strawderman RL
    Med Care; 2002 Aug; 40(8):650-61. PubMed ID: 12187179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experts' agency problems: evidence from the prescription drug market in Japan.
    Iizuka T
    Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of physician payment disclosure laws on prescribing.
    Pham-Kanter G; Alexander GC; Nair K
    Arch Intern Med; 2012 May; 172(10):819-21. PubMed ID: 22636826
    [No Abstract]   [Full Text] [Related]  

  • 17. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
    Rodwin MA
    J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal.
    Rodwin MA
    J Law Med Ethics; 2010; 38(4):807-15. PubMed ID: 21105944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.
    Mitchell AP; Winn AN; Dusetzina SB
    JAMA Intern Med; 2018 Jun; 178(6):854-856. PubMed ID: 29630687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' attitudes about gifts to physicians from pharmaceutical companies.
    Blake RL; Early EK
    J Am Board Fam Pract; 1995; 8(6):457-64. PubMed ID: 8585404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.